Title: |
Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management. |
Authors: |
Thakker, Ravi A., Salazar, Leonardo, Jazar, Deaa Abu, Bhakta, Pooja, Baker, Bryan, Patel, Chandani, Elbadawi, Ayman, Agarwal, Mayank, Albaeni, Aiham, Saleh, Mohammed, Esclovan, Jonathan, El Haddad, Danielle, Alwash, Hashim, Kalra, Ankur, Goel, Sachin S., Widmer, Robert Jay, Chatila, Khaled, Khalife, Wissam, Motiwala, Afaq, McCracken, Jennifer |
Source: |
Cardiology & Therapy; Jun2022, Vol. 11 Issue 2, p175-183, 9p |
Subject Terms: |
CORONARY artery disease, ASPIRIN, MYOCARDIAL ischemia, HEART valve diseases, CORONARY disease |
Abstract: |
Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomitant aspirin intolerance. Through an extensive review of the literature, we provide a comprehensive background on the pharmacology of aspirin, the mechanisms behind aspirin intolerance, the importance of aspirin in cardiovascular disease, and the management of aspirin intolerance in both acute coronary syndrome and stable coronary artery disease. Our review includes a multidisciplinary approach from the internist, allergist/immunologist, and cardiologist when evaluating this important patient population. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cardiology & Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Complementary Index |